Literature DB >> 25546763

Antibody-mediated vascular rejection of kidney allograft: characterization of different kidney allograft rejection phenotypes via histology, C4d deposition and donor-specific antibodies.

C Legendre1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25546763      PMCID： PMC4285492          DOI： 10.1111/cei.12512

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  11 in total

1.  Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN').

Authors:  K Solez; R B Colvin; L C Racusen; B Sis; P F Halloran; P E Birk; P M Campbell; M Cascalho; A B Collins; A J Demetris; C B Drachenberg; I W Gibson; P C Grimm; M Haas; E Lerut; H Liapis; R B Mannon; P B Marcus; M Mengel; M J Mihatsch; B J Nankivell; V Nickeleit; J C Papadimitriou; J L Platt; P Randhawa; I Roberts; L Salinas-Madriga; D R Salomon; D Seron; M Sheaff; J J Weening
Journal:  Am J Transplant       Date:  2007-03       Impact factor: 8.086

2.  Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation.

Authors:  Gary S Hill; Dominique Nochy; Patrick Bruneval; J P Duong van Huyen; Denis Glotz; Caroline Suberbielle; Julien Zuber; Dany Anglicheau; Jean-Philippe Empana; Christophe Legendre; Alexandre Loupy
Journal:  J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 10.121

3.  Banff 07 classification of renal allograft pathology: updates and future directions.

Authors:  K Solez; R B Colvin; L C Racusen; M Haas; B Sis; M Mengel; P F Halloran; W Baldwin; G Banfi; A B Collins; F Cosio; D S R David; C Drachenberg; G Einecke; A B Fogo; I W Gibson; D Glotz; S S Iskandar; E Kraus; E Lerut; R B Mannon; M Mihatsch; B J Nankivell; V Nickeleit; J C Papadimitriou; P Randhawa; H Regele; K Renaudin; I Roberts; D Seron; R N Smith; M Valente
Journal:  Am J Transplant       Date:  2008-02-19       Impact factor: 8.086

4.  Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA).

Authors:  A Loupy; G S Hill; C Suberbielle; D Charron; D Anglicheau; J Zuber; M O Timsit; J P Duong; P Bruneval; Dewi Vernerey; J P Empana; X Jouven; D Nochy; C H Legendre
Journal:  Am J Transplant       Date:  2011-01       Impact factor: 8.086

5.  Posttransplant prophylactic intravenous immunoglobulin in kidney transplant patients at high immunological risk: a pilot study.

Authors:  D Anglicheau; A Loupy; C Suberbielle; J Zuber; N Patey; L-H Noël; R Cavalcanti; M Le Quintrec; F Audat; A Méjean; F Martinez; M-F Mamzer-Bruneel; E Thervet; C Legendre
Journal:  Am J Transplant       Date:  2007-03-12       Impact factor: 8.086

6.  Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies.

Authors:  A Loupy; C Suberbielle-Boissel; G S Hill; C Lefaucheur; D Anglicheau; J Zuber; F Martinez; E Thervet; A Méjean; D Charron; J P Duong van Huyen; P Bruneval; C Legendre; D Nochy
Journal:  Am J Transplant       Date:  2009-09-22       Impact factor: 8.086

7.  Risk of antibody-mediated rejection in kidney transplant recipients with anti-HLA-C donor-specific antibodies.

Authors:  O Aubert; M-C Bories; C Suberbielle; R Snanoudj; D Anglicheau; M Rabant; F Martinez; A Scemla; C Legendre; R Sberro-Soussan
Journal:  Am J Transplant       Date:  2014-05-07       Impact factor: 8.086

8.  Outcome of kidney transplantations performed with preformed donor-specific antibodies of unknown etiology.

Authors:  A Sicard; L Amrouche; C Suberbielle; M Carmagnat; S Candon; E Thervet; M Delahousse; C Legendre; L Chatenoud; R Snanoudj
Journal:  Am J Transplant       Date:  2013-11-13       Impact factor: 8.086

9.  Antibody-mediated vascular rejection of kidney allografts: a population-based study.

Authors:  Carmen Lefaucheur; Alexandre Loupy; Dewi Vernerey; Jean-Paul Duong-Van-Huyen; Caroline Suberbielle; Dany Anglicheau; Jérôme Vérine; Thibaut Beuscart; Dominique Nochy; Patrick Bruneval; Dominique Charron; Michel Delahousse; Jean-Philippe Empana; Gary S Hill; Denis Glotz; Christophe Legendre; Xavier Jouven
Journal:  Lancet       Date:  2012-11-23       Impact factor: 79.321

10.  Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.

Authors:  M Haas; B Sis; L C Racusen; K Solez; D Glotz; R B Colvin; M C R Castro; D S R David; E David-Neto; S M Bagnasco; L C Cendales; L D Cornell; A J Demetris; C B Drachenberg; C F Farver; A B Farris; I W Gibson; E Kraus; H Liapis; A Loupy; V Nickeleit; P Randhawa; E R Rodriguez; D Rush; R N Smith; C D Tan; W D Wallace; M Mengel
Journal:  Am J Transplant       Date:  2014-02       Impact factor: 8.086
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.